Elicio Therapeutics (ELTX) Current Leases (2021 - 2026)
Elicio Therapeutics (ELTX) reported Current Leases of $1.0 million for Q1 2026, up 12.53% on a YoY basis from $926000.0 in Q1 2025, and up 3.07% quarter-over-quarter from $1.0 million in Q4 2025.
Elicio Therapeutics (ELTX) Current Leases (2021 - 2026) Analysis & Trends
Elicio Therapeutics has reported Current Leases for 6 years, with the latest figure at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 12.53% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 12.53% YoY), and the FY2025 full-year result was $1.0 million, up 12.21% from the prior year.
- Current Leases for Q1 2026 stood at $1.0 million, up from $1.0 million in the prior quarter.
- The five-year high for Current Leases was $1.0 million in Q1 2026, with the low at $60000.0 in Q1 2022.
- Historically, Current Leases has averaged $780411.8 across 5 years, with a median of $910000.0 in 2023.
- Annual changes were most pronounced in 2022 — Current Leases plunged 92.68% — and 2023, when it surged 1488.71%.
- Elicio Therapeutics' Current Leases stood at $692000.0 in 2022, then soared by 31.5% to $910000.0 in 2023, then fell by 0.99% to $901000.0 in 2024, then gained by 12.21% to $1.0 million in 2025, then rose by 3.07% to $1.0 million in 2026.
- The last three Current Leases figures came in at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $981000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 981,000.00 |
| Jun 30, 2025 | 952,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Dec 31, 2024 | 901,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Jun 30, 2024 | 854,000.00 |
| Mar 31, 2024 | 881,000.00 |
| Dec 31, 2023 | 910,000.00 |
| Sep 30, 2023 | 938,000.00 |
| Jun 30, 2023 | 985,000.00 |
| Mar 31, 2023 | 227,000.00 |
| Dec 31, 2022 | 692,000.00 |
| Sep 30, 2022 | 968,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 60,000.00 |
| Dec 31, 2021 | 894,000.00 |
| Sep 30, 2021 | 870,000.00 |
| Jun 30, 2021 | 847,000.00 |